BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Christensen M, Kamson DO, Snyder M, Kim H, Robinette NL, Mittal S, Juhász C. Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients. J Radiat Oncol 2014;3:131-8. [PMID: 25414765 DOI: 10.1007/s13566-013-0132-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Juhász C, Dwivedi S, Kamson DO, Michelhaugh SK, Mittal S. Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging 2014;13. [PMID: 24825818 DOI: 10.2310/7290.2014.00015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 11.3] [Reference Citation Analysis]
2 Challapalli A, Aboagye EO. Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response Monitoring. Front Oncol 2016;6:44. [PMID: 26973812 DOI: 10.3389/fonc.2016.00044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
3 John F, Bosnyák E, Robinette NL, Amit-Yousif AJ, Barger GR, Shah KD, Michelhaugh SK, Klinger NV, Mittal S, Juhász C. Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival. Neuro Oncol 2019;21:264-73. [PMID: 30346623 DOI: 10.1093/neuonc/noy169] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
4 Frosina G. Positron emission tomography of high-grade gliomas. J Neurooncol 2016;127:415-25. [PMID: 26897013 DOI: 10.1007/s11060-016-2077-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
5 Velásquez C, Mansouri S, Mora C, Nassiri F, Suppiah S, Martino J, Zadeh G, Fernández-Luna JL. Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells. J Oncol 2019;2019:1740763. [PMID: 31467533 DOI: 10.1155/2019/1740763] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
6 Choudhary G, Langen KJ, Galldiks N, McConathy J. Investigational PET tracers for high-grade gliomas. Q J Nucl Med Mol Imaging 2018;62:281-94. [PMID: 29869489 DOI: 10.23736/S1824-4785.18.03105-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Herholz K. Brain Tumors: An Update on Clinical PET Research in Gliomas. Semin Nucl Med 2017;47:5-17. [PMID: 27987557 DOI: 10.1053/j.semnuclmed.2016.09.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]